About: Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.13 (-1.66%)
PHAT NASDAQ Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc share price
PHAT price activity
Last Price
$7.130
Change (24hr)
-0.12 USD (-1.66%)
Volume
644.85K
Volume (4w avg)
-
Open
$7.25
Day Range
$7.13 - $7.25
Previous Close
$7.25
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
PHAT price performance
Delayed
12 Oct, 8:00 pm GMT+0
PHAT Market Signals